REPAGLINIDE 2 MG TABLET

Repaglinide
$0.0859per EA

Strength

2 mg/1

NDC

57237015901

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

REPAGLINIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203820

On Market Since

1/22/2014

Pharmacological Classes

Glinide
Potassium Channel Antagonists

Price History

1W

0.0%

1M

+0.1%

3M

-8.4%

6M

-8.5%

1Y

-26.6%

3Y

-23.8%

5Y

-39.9%

All

-66.3%